Expansion of India's Biotechnology Sector

India's biotechnology sector has witnessed a massive transformation over the last decade. Specifically, the industry grew from $10 billion to over $195 billion since 2014. Union Minister Dr. Jitendra Singh shared these details during a recent foundation day event in New Delhi. He attributed this success to enabling policies and strong government support. Moreover, the sector recorded an annual growth rate of roughly 18% in the last year alone. Consequently, the bioeconomy now contributes nearly 4.8% to India's national GDP.

Notably, this growth occurred despite global challenges like the COVID-19 pandemic. The minister highlighted that resilience remains a key driver of this progress. India's ability to persist under constraints has defined its innovation strength. Furthermore, the government has prioritized science and technology to build a robust ecosystem. Therefore, India is now on track to become the world’s third-largest economy soon.

The Strategic Role of BIRAC

The Biotechnology Industry Research Assistance Council (BIRAC) has played a critical role in this journey. Specifically, it has moved beyond random collaborations to a structured, outcome-driven approach. BIRAC identifies the right partners and provides targeted funding for innovators. Additionally, it offers mentorship and incubation support to strengthen industry-academia ties. Currently, over 11,800 biotech startups are powering this expanding ecosystem across the country.

Moreover, BIRAC has facilitated significant investment in deep-tech solutions. The agency now manages substantial funds to support later-stage advanced technology companies. Consequently, many laboratory ideas have successfully transitioned into market-ready solutions. This synergy between research and industry remains essential for long-term sustainability. Notably, the government’s BioE3 policy further strengthens bio-based industries and sustainable biomanufacturing efforts.

Overcoming Innovation Risks

Scientific innovation inherently involves high elements of risk and failure. However, Dr. Singh noted that true success lies in progressing despite these setbacks. He emphasized that failure is an integral part of the innovation process. Specifically, India's biotech journey is a story of growth in spite of significant adversities. Furthermore, the nation is steadily moving toward its target of a $300 billion bioeconomy by 2030. This ambitious goal relies on a strong base of scientists and entrepreneurs.

Frequently Asked Questions

Q1: What is the current valuation of India's biotechnology sector?

As of 2025, the sector has expanded to over $195.3 billion, growing from $10 billion in 2014.

Q2: What is the government's future target for the bioeconomy?

The Indian government aims to reach a $300 billion biotechnology valuation by the year 2030.

Q3: How many biotech startups currently operate in India?

There are now more than 11,800 biotechnology startups contributing to the innovation ecosystem in India.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. India’s biotech sector grows from $10 bn to over $195 bn in a decade: JitendraSingh - ETHealthworld


2. India BioEconomy Report (IBER) 2026 - Biotechnology Industry Research Assistance Council (BIRAC)


3. PIB Delhi: India's Bioeconomy surges from $10 billion to $195 billion in a decade, Registers 17–18% Annual Growth